Seelos Therapeutics Receives FDA Fast Track Designation for Intranasal Racemic Ketamine (SLS-002)

    NEXT STORY
    RenovaCare Appoints Alan L. Rubino as President and CEO
    PREV STORY
    BioSig Technologies Welcomes the Creation of New Bioelectronic Medicine Alliance
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Novavax Appoints Rachel King to Board of Directors

    GAITHERSBURG, Md., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq: NVAX) today announced ...

    author_avatar
    NASDAQ Market News

    Boston Therapeutics Engages Medical and FDA Experts: Launching New Strategic Initiatives

    LAWRENCE, Mass., March 29, 2018 (GLOBE NEWSWIRE) -- Boston Therapeutics, an innovator in the ...

    author_avatar
    NASDAQ Market News

    Oasmia tillsätter Business Advisory Board

    author_avatar
    NASDAQ Market News